#Cancer is unusual cell growth with the eventually to invade or spread to whole body. Not all tumors are cancerous. Possible signs and symptoms include a abnormal bleeding, prolonged cough, lump, weight loss and a change in bowel movements. While these signs may specify cancer, they may have other reasons. Over 100 #cancers affect humans. Avoiding smoking, maintaining a healthy weight, control on alcohol consumption, eating plenty of vegetables, fruits and whole grains, vaccination against certain #, control on consumption of eating too much processed and red meat, and avoiding too much sunlight exposure can be prevent many cancers.
According to the market the global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.
